Afternoon:
10°c
Divi cuts on way as Pfizer grabs Wyeth
Lucy Tobin26 Jan 2009
Pfizer, the world's biggest drugs company, today bought rival Wyeth for £50 billion.
Viagra maker Pfizer raised $22.5 billion (£16.2 billion) from a consortium of banks to finance the buy, and said that it will be cutting its dividends.
The deal is regarded as a protective move by US-based Pfizer, which is anticipating a huge fall in profits when its popular anti-cholesterol drug Lipitor comes out of patent protection in 2011.
The deal is the largest in the sector since Pfizer bought Warner-Lambert for $93.4 billion in 2000. Analysts believe it could inspire a wave of consolidation in the cash-rich pharmaceuticals industry as drug firms look to lessen the impact of generic drug alternatives.
“Deals of this quality and this magnitude will rekindle enthusiasm and hope about equity markets,” said Andre Bakhos of Princeton Financial Group.
“In the midst of a global recession, here is Pfizer, hopefully spending their dollars wisely.
Reader views (1)
Raising billions for another buy out and yet announcing redundancies at the Sandwich, Kent headquarters and finishing all drug production at the same plant.
- Terence Harrington, Canterybury, UK, 26/01/2009 18:10
Report abuse
